These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
134 related items for PubMed ID: 8326383
1. Radioimmunodetection of medullary thyroid cancer using a bispecific anti-CEA/anti-indium-DTPA antibody and an indium-111-labeled DTPA dimer. Peltier P, Curtet C, Chatal JF, Le Doussal JM, Daniel G, Aillet G, Gruaz-Guyon A, Barbet J, Delaage M. J Nucl Med; 1993 Aug; 34(8):1267-73. PubMed ID: 8326383 [Abstract] [Full Text] [Related]
2. Radioimmunodetection of medullary thyroid carcinoma using indium-111 bivalent hapten and anti-CEA x anti-DTPA-indium bispecific antibody. Barbet J, Peltier P, Bardet S, Vuillez JP, Bachelot I, Denet S, Olivier P, Leccia F, Corcuff B, Huglo D, Proye C, Rouvier E, Meyer P, Chatal JF. J Nucl Med; 1998 Jul; 39(7):1172-8. PubMed ID: 9669389 [Abstract] [Full Text] [Related]
4. Biodistribution and dosimetric study in medullary thyroid cancer xenograft using bispecific antibody and iodine-125-labeled bivalent hapten. Hosono M, Hosono MN, Kraeber-Bodéré F, Devys A, Thédrez P, Fiche M, Gautherot E, Barbet J, Chatal JF. J Nucl Med; 1998 Sep; 39(9):1608-13. PubMed ID: 9744353 [Abstract] [Full Text] [Related]
5. Immunoscintigraphy using 111In-labeled F(ab')2 fragments of anticarcinoembryonic antigen monoclonal antibody for detecting recurrences of medullary thyroid carcinoma. Vuillez JP, Peltier P, Caravel JP, Chetanneau A, Saccavini JC, Chatal JF. J Clin Endocrinol Metab; 1992 Jan; 74(1):157-63. PubMed ID: 1727816 [Abstract] [Full Text] [Related]
6. Pretargeting of renal cell carcinoma: improved tumor targeting with a bivalent chelate. Boerman OC, Kranenborg MH, Oosterwijk E, Griffiths GL, McBride WJ, Oyen WJ, de Weijert M, Oosterwijk-Wakka J, Hansen HJ, Corstens FH. Cancer Res; 1999 Sep 01; 59(17):4400-5. PubMed ID: 10485489 [Abstract] [Full Text] [Related]
9. Bispecific monoclonal antibody-mediated targeting of an indium-111-labeled DTPA dimer to primary colorectal tumors: pharmacokinetics, biodistribution, scintigraphy and immune response. Le Doussal JM, Chetanneau A, Gruaz-Guyon A, Martin M, Gautherot E, Lehur PA, Chatal JF, Delaage M, Barbet J. J Nucl Med; 1993 Oct 01; 34(10):1662-71. PubMed ID: 8410279 [Abstract] [Full Text] [Related]
10. Pretargeting with labeled bivalent peptides allowing the use of four radionuclides: (111)In, (131)I, (99m)Tc, and (188)Re. van Schaijk FG, Oosterwijk E, Soede AC, Oyen WJ, McBride WJ, Griffiths GL, Goldenberg DM, Corstens FH, Boerman OC. Clin Cancer Res; 2003 Sep 01; 9(10 Pt 2):3880S-5S. PubMed ID: 14506186 [Abstract] [Full Text] [Related]